Alaunos Therapeutics | ZIOP - Gross Profit On Sales


Alaunos Therapeutics reported $-1.13M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Amgen USD 5.87B 1.02B Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
Baxter International USD 1.14B 251M Jun/2026
Biogen USD 2.12B 307M Jun/2026
Bioline Rx USD 382K 39K Mar/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Celltrion KRW 39.29B 7.7B Mar/2026
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Curis USD 1.14M 8.86M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Incyte USD 1.57B 400.89M Jun/2026
Intrexon USD -297K 167K Jun/2024
Ionis Pharmaceuticals USD 265M 22M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Karyopharm Therapeutics USD 33.72M 1.13M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Merck USD 12.09B 1.24B Mar/2026
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Novartis USD 11.24B 1.18B Jun/2026
Organigram Holdings CAD 16.41M 6.91M Mar/2026
Pfizer USD -248M 11.29B Jun/2026
Pharma Mar EUR 44.87M 5.63M Jun/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Qiagen NV USD 340.39M 30.78M Jun/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sartorius EUR 433.1M 18.6M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
TG Therapeutics USD 199.14M 27.73M Jun/2026
Tilray USD 57.47M 10.16M Jun/2025
Verastem USD 15.62M 977K Mar/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026